Biogen: Clinical Trials & Research Profile

Biopharma Industry (Cambridge, MA) · Primary Focus: Neurology, Psychiatry, and Pain

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Cambridge, MA)
Primary Therapeutic AreaNeurology, Psychiatry, and Pain
Active Phase II & III Studies22 active (11 recruiting now)
Total Tracked Studies (2018 to 2026)61 (47 with California sites)
Completed vs Early-Stopped Studies19 completed / 20 stopped (32.8% stop rate)
Median Closed Enrollment155 participants
FDA Drugs@FDA Original Approvals12 all-time (6 from 2018 to 2026)
Physical Hospital Site Disclosure84.6% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Biogen across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk